{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Tetrahydroisoquinoline compounds as estrogen agonists/antagonists", "item": "https://www.patentleaderboard.com/patent/6608203"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

Tetrahydroisoquinoline compounds as estrogen agonists/antagonists

US Patent 6608203 · Granted Aug 19, 2003

Estimated economic value: $165,603,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists2025
BCKDK inhibitors and/or degraders2025
Aryl-or heteroaryl-substituted benzene compounds2024
Aryl-OR heteroaryl-substituted benzene compounds2024
Aryl-or heteroaryl-substituted benzene compounds2024
Carm1 inhibitors and uses thereof2023
Method of treating leukemia2023
Arginine methyltransferase inhibitors and uses thereof2022
Anti-ApoC3 antibodies2022
Polynucleotides encoding anti-ApoC3 antibodies2022
Anti-ApoC3 antibodies and methods of use thereof2022
Anti-proliferative agents for treating PAH2021